Type 1 Diabetes Clinical Trial
— UNIQUEOfficial title:
Observational Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update
Verified date | March 2022 |
Source | Kinderkrankenhaus auf der Bult |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this observational clinical trial is to obtain data on the safety, efficacy and satisfaction of the Tandem T:Slim X:2 Pump System in patients with type 1 diabetes.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 28, 2021 |
Est. primary completion date | December 28, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 45 Years |
Eligibility | Inclusion Criteria: 1. signed informed consent 2. type 1 diabetes 3. Age >6 years 4. at least 10 IE daily total Insulin dose and 25 kg Body weight 5. Group SWITCH: already user of t:slim X2 with Basal IQ 6. Group START: Granting of the insulin pump t:slim X2 and DexCom G6 by the health insurance Exclusion Criteria: 1.Refusal of participation by the participant or a parent |
Country | Name | City | State |
---|---|---|---|
Germany | Hospital for Children and Adolescents AUF DER BULT | Hanover | Lower Saxony |
Lead Sponsor | Collaborator |
---|---|
Kinderkrankenhaus auf der Bult |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time in glucose range 70 - 180mg/dl (%) | Both groups are evaluated together. Comparison of the time (%) in the glucose range 70 - 180mg/dl of the last two weeks of the study with the time in the target range two weeks before the start of the study. | 12 weeks | |
Secondary | user satisfaction assessed by disabkids questionnaire for children and for parents | Comparison of both groups with regard to satisfaction via specific validated questionnaire at the start of the study | two weeks | |
Secondary | user satisfaction assessed by disabkids questionnaire for children and for parents | Evaluation of the satisfaction of users via specific validated questionnare at the beginning and the end of study | 12 weeks | |
Secondary | mean glucose level [mg/dl] | Comparison of the mean Glucose Level from glucose sensor [mg/dl] of the last two study weeks with the mean glucose Level two weeks before the start of the study. | two weeks | |
Secondary | mean glucose Level before study start [mg/dl] | Comparison of both groups concerning the mean glucose level of the two weeks before the start of the study. | two weeks | |
Secondary | mean daily insulin amount | Both groups are evaluated together. Comparison of the mean daily insulin amount (U/kgBW/d) (U/kgBW/d) of the last two study weeks with the insulin amount two weeks before the start of the study. | 12 weeks | |
Secondary | mean daily insulin amount before study start | Comparison of both groups concerning the mean daily insulin amount (U/kgBW/d) of the two weeks before the start of the study. | two weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02750527 -
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
|
||
Completed |
NCT02855307 -
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
|
Phase 2 |